NIM
NRIX icon

NEOS Investment Management’s Nurix Therapeutics NRIX Stock Holding History

NEOS Investment Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77,775
Closed -$1.48M – 629
2025
Q4 		$1.48M Buy
77,775
+33,043
+74% +$475K 0.01% 507
2025
Q3 		$413K Sell
44,732
-36,380
-45% -$378K ﹤0.01% 591
2025
Q2 		$924K Buy
81,112
+21,966
+37% +$237K 0.01% 481
2025
Q1 		$703K Buy
59,146
+36,589
+162% +$612K 0.01% 481
2024
Q4 		$425K Buy
+22,557
New +$517K 0.01% 526

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

NEOS Investment Management's NRIX Position: Q1 2026 in Review

NEOS Investment Management sold out of Nurix Therapeutics (NRIX) in Q1 2026, closing a stake of 77,775 shares — an estimated $1.48M sold.

NEOS Investment Management first reported a position in NRIX in Q4 2024 and held it in 5 quarters. The position peaked at $1.48M in Q4 2025. 196 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • NEOS Investment Management reported no remaining Nurix Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 77,775 Nurix Therapeutics shares in Q1 2026, an estimated $1.48M.
  • NEOS Investment Management first reported a position in Nurix Therapeutics in Q4 2024 and held it in 5 quarters.
  • NEOS Investment Management's Nurix Therapeutics position peaked at $1.48M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.